Table 3.
Analysis of factors related to postoperative tumor recurrence.
| Recurrence | Non-Recurrence | P Value | ||
|---|---|---|---|---|
| Surgical Approach | Craniotomy | 14 (22.6%) | 48 (77.4%) | p=0.07 |
| Endoscopic endonasal transsphenoidal | 4 (57.1%) | 3 (42.9%) | ||
| Primary or Recurrence Tumor | Primary | 16 (25.0%) | 48 (75.0%) | p=0.60 |
| Recurrence | 2 (40.0%) | 3 (60.0%) | ||
| rhGH Therapy | Yes | 4 (18.2%) | 18 (81.8%) | p=0.31 |
| No | 14 (29.8%) | 33 (70.2%) |
rhGH, recombinant human growth hormone.